Company / Operating Margin
Cardiff Oncology, Inc. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-8256.3%
FY2025
5-year range
-10337.3% / -5214.8%
FY2021-FY2025
Trend
+11.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has fluctuated over the past 10 years, ranging from -10534.9% in FY2017 to -5064.4% in FY2018.
Based on SEC 10-K filings.
-8256.3% in FY2025 with a 5-year CAGR of -3041.5%.
Improved from -10337.3% to -8256.3% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -218.7pp
- 5-Year Change
- -3041.5pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin increased 11.3% year-over-year.
- Peak operating margin was recorded in FY2018.
- Lowest operating margin in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -8256.3% | +11.3% |
| FY2024 | -9305.7% | +10.0% |
| FY2023 | -10337.3% | -28.6% |
| FY2022 | -8037.6% | -54.1% |
| FY2021 | -5214.8% | +0.0% |
| FY2020 | -5214.8% | +23.5% |
| FY2019 | -6817.8% | -34.6% |
| FY2018 | -5064.4% | +51.9% |
| FY2017 | -10534.9% | -97.5% |
| FY2016 | -5334.2% | +34.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026